Previous studies have shown that Tregs, CSCs, and CD8/Treg ratios are positively associated with BC disease progression [43]; however, in the present study, Tregs and CD8 T-cell infiltration were lower in the high-risk BC patients, possibly due to the more important role of other immune cells and tumor-promoting regulators in the TIME. The gene discussed is CD8A; the disease is neoplasm.